Acasti to Participate in Upcoming San Francisco Investor Conferences in January 2024

December 15, 2023

https://www.globenewswire.com/news-release/2023/12/13/2795501/0/en/Acasti-to-Participate-in-Upcoming-San-Francisco-Investor-Conferences-in-January-2024.html

PRINCETON, N.J., Dec. 13, 2023 (GLOBE NEWSWIRE) — Acasti Pharma Inc. (Nasdaq:ACST) (Acasti or the Company), a late-stage, biopharma company advancing GTX-104, its novel intravenous formulation of nimodipine being developed to address the high unmet medical needs for a rare disease, aneurysmal Subarachnoid Hemorrhage (aSAH), today announced that Chief Executive Officer Prashant Kohli will participate in the following investor and industry networking events in San Francisco, California during the week of January 7-12, 2024.

Read more at globenewswire.com

Related news for (ACST)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.